Published online Sep 6, 2023. doi: 10.12998/wjcc.v11.i25.5840
Peer-review started: June 3, 2023
First decision: June 14, 2023
Revised: July 6, 2023
Accepted: August 7, 2023
Article in press: August 7, 2023
Published online: September 6, 2023
Processing time: 89 Days and 14.9 Hours
Insulin, a small protein with 51 amino acids synthesized by pancreatic β-cells, is crucial to sustain glucose homeostasis at biochemical and molecular levels. Numerous metabolic dysfunctions are related to insulin-mediated altered glucose homeostasis. One of the significant pathophysiological conditions linked to the insulin associated disorder is diabetes mellitus (DM) (type 1, type 2, and gestational). Insulin resistance (IR) is one of the major underlying causes of metabolic disorders despite its association with several physiological conditions. Metabolic syndrome (MS) is another pathophysiological condition that is associated with IR, hypertension, and obesity. Further, several other patho
Core Tip: Insulin mediated glucose homeostasis is an important event in human physiology as it fuels the life. Malfunctioning of insulin and its secretion has been linked to initiation and progression of altered pathophysiological conditions at biochemical and molecular levels. This review will help the scientific community to understand the biochemical and molecular axis of insulin-related disorders and associated pathophysiological complications and thus devise their treatment strategy.